Clinical Trial Update: Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules [Phase 1]

View source ↗

Summary

Pfizer completed a pivotal Phase 1 bioequivalence study to qualify a manufacturing site transfer for prazosin hydrochloride capsules. Results were posted on 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Prazosin hydrochloride capsules (prazosin)

Snippet

Sponsor: Pfizer | Conditions: Hypertension, Heart Failure | Phase 1 | Status: COMPLETED | Results posted: 2024-07-12